Julia Bohannon
Last active: 12/1/2020


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. The Metabolic Basis of Immune Dysfunction Following Sepsis and Trauma. McBride MA, Owen AM, Stothers CL, Hernandez A, Luan L, Burelbach KR, Patil TK, Bohannon JK, Sherwood ER, Patil NK (2020) Front Immunol : 1043
    › Primary publication · 32547553 (PubMed) · PMC7273750 (PubMed Central)
  2. Immunobiology and application of toll-like receptor 4 agonists to augment host resistance to infection. Hernandez A, Patil NK, Stothers CL, Luan L, McBride MA, Owen AM, Burelbach KR, Williams DL, Sherwood ER, Bohannon JK (2019) Pharmacol Res : 104502
    › Primary publication · 31689522 (PubMed) · PMC6884699 (PubMed Central)
  3. Phosphorylated Hexa-Acyl Disaccharides Augment Host Resistance Against Common Nosocomial Pathogens. Hernandez A, Luan L, Stothers CL, Patil NK, Fults JB, Fensterheim BA, Guo Y, Wang J, Sherwood ER, Bohannon JK (2019) Crit Care Med 47(11): e930-e938
    › Primary publication · 31567352 (PubMed) · PMC6791756 (PubMed Central)
  4. Monophosphoryl Lipid a Attenuates Multiorgan Dysfunction During Post-Burn Pseudomonas Aeruginosa Pneumonia in Sheep. Fukuda S, Ihara K, Bohannon JK, Hernandez A, Patil NK, Luan L, Stothers C, Stark R, Prough DS, Herndon DN, Sherwood ER, Enkhbaatar P (2020) Shock 53(3): 307-316
    › Primary publication · 31045990 (PubMed) · PMC6937402 (PubMed Central)
  5. Regulation of leukocyte function by citric acid cycle intermediates. Patil NK, Bohannon JK, Hernandez A, Patil TK, Sherwood ER (2019) J Leukoc Biol 106(1): 105-117
    › Primary publication · 30791134 (PubMed) · PMC6597293 (PubMed Central)
  6. Metabolism drives monocytes during inflammation: What we do and do not know. Patil NK, Bohannon JK, Sherwood ER (2019) J Leukoc Biol 105(2): 211-213
    › Primary publication · 30618209 (PubMed)
  7. Hypoxia-inducible factor-1α regulation of myeloid cells. Stothers CL, Luan L, Fensterheim BA, Bohannon JK (2018) J Mol Med (Berl) 96(12): 1293-1306
    › Primary publication · 30386909 (PubMed) · PMC6292431 (PubMed Central)
  8. What's New in Shock, July 2018? Bohannon JK, Sherwood ER (2018) Shock 50(1): 1-4
    › Primary publication · 29889806 (PubMed)
  9. The TLR4 Agonist Monophosphoryl Lipid A Drives Broad Resistance to Infection via Dynamic Reprogramming of Macrophage Metabolism. Fensterheim BA, Young JD, Luan L, Kleinbard RR, Stothers CL, Patil NK, McAtee-Pereira AG, Guo Y, Trenary I, Hernandez A, Fults JB, Williams DL, Sherwood ER, Bohannon JK (2018) J Immunol 200(11): 3777-3789
    › Primary publication · 29686054 (PubMed) · PMC5964009 (PubMed Central)
  10. Frontline Science: Anti-PD-L1 protects against infection with common bacterial pathogens after burn injury. Patil NK, Luan L, Bohannon JK, Hernandez A, Guo Y, Sherwood ER (2018) J Leukoc Biol 103(1): 23-33
    › Primary publication · 29345058 (PubMed)
  11. The biology of natural killer cells during sepsis. Guo Y, Patil NK, Luan L, Bohannon JK, Sherwood ER (2018) Immunology 153(2): 190-202
    › Primary publication · 29064085 (PubMed) · PMC5765373 (PubMed Central)
  12. The Cytokine Response to Lipopolysaccharide Does Not Predict the Host Response to Infection. Fensterheim BA, Guo Y, Sherwood ER, Bohannon JK (2017) J Immunol 198(8): 3264-3273
    › Primary publication · 28275139 (PubMed) · PMC5380530 (PubMed Central)
  13. Fms-like tyrosine kinase-3 ligand increases resistance to burn wound infection through effects on plasmacytoid dendritic cells. Bae L, Bohannon JK, Cui W, Vinish M, Toliver-Kinsky T (2017) BMC Immunol 18(1): 9
    › Primary publication · 28228109 (PubMed) · PMC5322596 (PubMed Central)
  14. Comparative Transcriptome Profiles of Human Blood in Response to the Toll-like Receptor 4 Ligands Lipopolysaccharide and Monophosphoryl Lipid A. Luan L, Patil NK, Guo Y, Hernandez A, Bohannon JK, Fensterheim BA, Wang J, Xu Y, Enkhbaatar P, Stark R, Sherwood ER (2017) Sci Rep : 40050
    › Primary publication · 28053314 (PubMed) · PMC5215261 (PubMed Central)
  15. IL-15 Enables Septic Shock by Maintaining NK Cell Integrity and Function. Guo Y, Luan L, Patil NK, Wang J, Bohannon JK, Rabacal W, Fensterheim BA, Hernandez A, Sherwood ER (2017) J Immunol 198(3): 1320-1333
    › Primary publication · 28031340 (PubMed) · PMC5263185 (PubMed Central)
  16. Editorial: Feeling the burn: sphingolipids and infection risk after thermal injury. Bohannon JK, Sherwood ER (2016) J Leukoc Biol 100(6): 1227-1228
    › Primary publication · 27909176 (PubMed)
  17. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression. Patil NK, Bohannon JK, Sherwood ER (2016) Pharmacol Res : 688-702
    › Primary publication · 27468649 (PubMed) · PMC5026606 (PubMed Central)
  18. Flt3 Ligand Treatment Attenuates T Cell Dysfunction and Improves Survival in a Murine Model of Burn Wound Sepsis. Patil NK, Bohannon JK, Luan L, Guo Y, Fensterheim B, Hernandez A, Wang J, Sherwood ER (2017) Shock 47(1): 40-51
    › Primary publication · 27454384 (PubMed) · PMC5167662 (PubMed Central)
  19. The role of MyD88- and TRIF-dependent signaling in monophosphoryl lipid A-induced expansion and recruitment of innate immunocytes. Hernandez A, Bohannon JK, Luan L, Fensterheim BA, Guo Y, Patil NK, McAdams C, Wang J, Sherwood ER (2016) J Leukoc Biol 100(6): 1311-1322
    › Primary publication · 27354411 (PubMed) · PMC5109999 (PubMed Central)
  20. IL-15 Superagonist Expands mCD8+ T, NK and NKT Cells after Burn Injury but Fails to Improve Outcome during Burn Wound Infection. Patil NK, Luan L, Bohannon JK, Guo Y, Hernandez A, Fensterheim B, Sherwood ER (2016) PLoS One 11(2): e0148452
    › Primary publication · 26859674 (PubMed) · PMC4747596 (PubMed Central)
  21. Role of G-CSF in monophosphoryl lipid A-mediated augmentation of neutrophil functions after burn injury. Bohannon JK, Luan L, Hernandez A, Afzal A, Guo Y, Patil NK, Fensterheim B, Sherwood ER (2016) J Leukoc Biol 99(4): 629-40
    › Primary publication · 26538529 (PubMed) · PMC4787290 (PubMed Central)
  22. IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ. Guo Y, Luan L, Rabacal W, Bohannon JK, Fensterheim BA, Hernandez A, Sherwood ER (2015) J Immunol 195(5): 2353-64
    › Primary publication · 26216888 (PubMed) · PMC4543906 (PubMed Central)
  23. The role of CXCL10 in the pathogenesis of experimental septic shock. Herzig DS, Luan L, Bohannon JK, Toliver-Kinsky TE, Guo Y, Sherwood ER (2014) Crit Care 18(3): R113
    › Primary publication · 24890566 (PubMed) · PMC4075230 (PubMed Central)
  24. The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants. Bohannon JK, Hernandez A, Enkhbaatar P, Adams WL, Sherwood ER (2013) Shock 40(6): 451-62
    › Primary publication · 23989337 (PubMed) · PMC3919163 (PubMed Central)
  25. The role of natural killer cells in the pathogenesis of sepsis: the ongoing enigma. Bohannon J, Guo Y, Sherwood ER (2012) Crit Care 16(6): 185
    › Primary publication · 23234545 (PubMed) · PMC3672611 (PubMed Central)
  26. Hippocampal CA1 transcriptional profile of sleep deprivation: relation to aging and stress. Porter NM, Bohannon JH, Curran-Rauhut M, Buechel HM, Dowling AL, Brewer LD, Popovic J, Thibault V, Kraner SD, Chen KC, Blalock EM (2012) PLoS One 7(7): e40128
    › Primary publication · 22792227 (PubMed) · PMC3390348 (PubMed Central)
  27. STAT1-deficient mice are resistant to cecal ligation and puncture-induced septic shock. Herzig D, Fang G, Toliver-Kinsky TE, Guo Y, Bohannon J, Sherwood ER (2012) Shock 38(4): 395-402
    › Primary publication · 22777121 (PubMed) · PMC3445722 (PubMed Central)
  28. Dendritic cell modification of neutrophil responses to infection after burn injury. Bohannon J, Cui W, Sherwood E, Toliver-Kinsky T (2010) J Immunol 185(5): 2847-53
    › Primary publication · 20679533 (PubMed) · PMC3100157 (PubMed Central)
  29. Fms-like tyrosine kinase-3 ligand alters antigen-specific responses to infections after severe burn injury. Bohannon J, Fang G, Cui W, Sherwood E, Toliver-Kinsky T (2009) Shock 32(4): 435-41
    › Primary publication · 19752689 (PubMed) · PMC3100155 (PubMed Central)
  30. Endogenous Fms-like tyrosine kinase-3 ligand levels are not altered in mice after a severe burn and infection. Bohannon JK, Cui W, Toliver-Kinsky T (2009) BMC Immunol : 47
    › Primary publication · 19715582 (PubMed) · PMC2744912 (PubMed Central)
  31. Prophylactic treatment with fms-like tyrosine kinase-3 ligand after burn injury enhances global immune responses to infection. Bohannon J, Cui W, Cox R, Przkora R, Sherwood E, Toliver-Kinsky T (2008) J Immunol 180(5): 3038-48
    › Primary publication · 18292526 (PubMed)